entertainment -WSS

entertainment

author：explore 2025-09-28 02:27:24 - browse：572

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： PBM reform efforts get punted in Congress

WSS

FTC loses bid to block Novant's North Carolina hospital merger

ASCO Daily Recap: CAR

Take antibiotics after sex, CDC recommends for certain risk groups

Dario to buy mental health app maker Twill in cash and stock deal

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Obesity drugs seen as possible treatment for liver disease MASH

knowledge

entertainment

entertainment

Drug repurposing or repositioning? The language matters

ASCO Daily Recap: CAR

In Memoriam: Notable people who died in 2023

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Alabama hospital puts IVF treatments on hold

Medical records are filled with copy

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Why palliative psychiatry is worth discussing

entertainment

BD to buy Edwards patient monitoring unit for $4.2 billion

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Anthony Fauci pushes back on GOP claims during Covid hearing

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Community Health Systems hospitals under DOJ investigation

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

entertainment

entertainment

leisure time

Wikipedia